Safety and Tolerability of Oxymetazoline and Energy-Based Therapy in Participants With Rosacea
Public ClinicalTrials.gov record NCT03380390. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter, Open-Label, Interventional Study on the Safety and Tolerability of Oxymetazoline and Energy-Based Therapy in Subjects With Rosacea
Study identification
- NCT ID
- NCT03380390
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Aclaris Therapeutics, Inc.
- Industry
- Enrollment
- 46 participants
Conditions and interventions
Conditions
Interventions
- Oxymetazoline HCL 1.0% Cream Drug
- Energy-Based Therapy Device
Drug · Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 3, 2017
- Primary completion
- Jun 14, 2018
- Completion
- Jun 14, 2018
- Last update posted
- Sep 3, 2019
2017 – 2018
United States locations
- U.S. sites
- 4
- U.S. states
- 4
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Center for Dermatology and Laser Surgery | Sacramento | California | 95819 | — |
| SkinCare Physicians | Chestnut Hill | Massachusetts | 02467 | — |
| Skin Laser and Surgery Specialists of NY/NJ | Hackensack | New Jersey | 07601 | — |
| Laser & Skin Surgery Center of New York Professional Corporation | New York | New York | 10016 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03380390, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 3, 2019 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03380390 live on ClinicalTrials.gov.